New study reveals racial disparities in voice box-preserving cancer treatment

July 16, 2012

A new epidemiological study led by UC Davis researchers reveals significant racial disparities in the use of non-surgical larynx-preservation therapy for locally advanced laryngeal cancer.

A review of medical records between 1991 and 2008 from across the country reveals that over 80 percent of white patients received combined with chemotherapy that preserves the larynx, or voice box. Only 74.5 percent of African American patients received this same treatment, with the remainder undergoing surgery that removed the larynx altogether, a procedure that has a dramatic effect on quality of life.

Just published online in the American Medical Association's Archives of Otolaryngology - , the paper analyzes treatment trends among 5,385 white, black, Latino and with stage III and IV laryngeal cancers. Records were culled from the 's (NCI) Surveillance Epidemiology and End Results program, which collects information on , prevalence and survival from specific geographic areas representing 28 percent of the U.S. population.

"We believe that future research should focus on identifying and eliminating barriers to the use of larynx-preservation for all medically suitable patients, with a particular focus on black patients," says lead author Allen Chen, an assistant professor in the UC Davis Department of Radiation Oncology.

Non-surgical therapy using with concurrent chemotherapy confers a high rate of voice conservation without adversely affecting survival for selected patients diagnosed with locally advanced cancers of the larynx.

Before larynx-preserving treatment gained widespread acceptance in recent decades, the standard of care for essentially all patients with locally advanced laryngeal cancer was initial surgical removal of the larynx, called a total laryngectomy. These patients suffer from more , pain and depression than patients with an intact larynx. They often develop chronic shoulder pain and sleep disturbances, and they experience worse social functioning and isolation as a result of speech impairment and body disfigurement.

While researchers observed a marked disparity between the study's white and black populations, differences were less pronounced for the Latino and Asian groups, with 78 percent of Latinos and 75.6 percent of Asians receiving larynx-preserving treatment. The observed gap between whites and blacks may also be narrowing, as the use of larynx-preservation is increasing among black patients over time.

"Further studies are needed to elicit the root causes of the current treatment disparities between whites and blacks, but it seems likely that critical factors include income, education and insurance differences, along with a lack of access to appropriate radiation facilities," says Chen, who also serves as the UC Davis Department of 's residency training program director.

Chen points out that the best treatment facilities can be found at the nation's 41 NCI-designated comprehensive cancer centers, as these institutions feature not only the latest technologies but also in-depth counseling and therapy both for medical decision-making and post-treatment management.

"Larynx preservation requires close coordination of care involving multiple specialists, including radiation oncologists, medical oncologists, otolaryngologists, speech pathologists, swallowing therapists, dentists and nutritionists, among many others," he said. "Having all of these services available in centers such as the UC Davis Comprehensive Cancer Center makes treatment a lot more feasible for patients."

Explore further: Donor aortic graft improves reconstruction after partial laryngectomy

More information: Arch Otolaryngol Head Neck Surg. 2012:138[7]:644-649.

Related Stories

Donor aortic graft improves reconstruction after partial laryngectomy

May 21, 2012
Massachusetts General Hospital (MGH) surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer. In the May Annals of Otology, Rhinology and Laryngology, they describe how this ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.